Hansson O - Search Results

1

Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer's disease.

Whelan CD, Mattsson N, Nagle MW, Vijayaraghavan S, Hyde C, Janelidze S, Stomrud E, Lee J, Fitz L, Samad TA, Ramaswamy G, Margolin RA, Malarstig A, Hansson O. Whelan CD, et al. Among authors: hansson o. Acta Neuropathol Commun. 2019 Nov 6;7(1):169. doi: 10.1186/s40478-019-0795-2. Acta Neuropathol Commun. 2019. PMID: 31694701 Free PMC article.

2

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.

Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L. Hansson O, et al. Lancet Neurol. 2006 Mar;5(3):228-34. doi: 10.1016/S1474-4422(06)70355-6. Lancet Neurol. 2006. PMID: 16488378

3

Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.

Hansson O, Zetterberg H, Buchhave P, Andreasson U, Londos E, Minthon L, Blennow K. Hansson O, et al. Dement Geriatr Cogn Disord. 2007;23(5):316-20. doi: 10.1159/000100926. Epub 2007 Mar 19. Dement Geriatr Cogn Disord. 2007. PMID: 17374949

4

Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly.

Stomrud E, Hansson O, Blennow K, Minthon L, Londos E. Stomrud E, et al. Among authors: hansson o. Dement Geriatr Cogn Disord. 2007;24(2):118-24. doi: 10.1159/000105017. Epub 2007 Jul 2. Dement Geriatr Cogn Disord. 2007. PMID: 17622715

5

Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease.

Hansson O, Buchhave P, Zetterberg H, Blennow K, Minthon L, Warkentin S. Hansson O, et al. Neurobiol Aging. 2009 Feb;30(2):165-73. doi: 10.1016/j.neurobiolaging.2007.06.009. Epub 2007 Jul 23. Neurobiol Aging. 2009. PMID: 17646035

6

CSF Mg and Ca as diagnostic markers for dementia with Lewy bodies.

Boström F, Hansson O, Gerhardsson L, Lundh T, Minthon L, Stomrud E, Zetterberg H, Londos E. Boström F, et al. Among authors: hansson o. Neurobiol Aging. 2009 Aug;30(8):1265-71. doi: 10.1016/j.neurobiolaging.2007.10.018. Epub 2008 Jan 8. Neurobiol Aging. 2009. PMID: 18191875

7

Slowing of EEG correlates with CSF biomarkers and reduced cognitive speed in elderly with normal cognition over 4 years.

Stomrud E, Hansson O, Minthon L, Blennow K, Rosén I, Londos E. Stomrud E, et al. Among authors: hansson o. Neurobiol Aging. 2010 Feb;31(2):215-23. doi: 10.1016/j.neurobiolaging.2008.03.025. Neurobiol Aging. 2010. PMID: 18462837

8

Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment.

Hansson O, Zetterberg H, Vanmechelen E, Vanderstichele H, Andreasson U, Londos E, Wallin A, Minthon L, Blennow K. Hansson O, et al. Neurobiol Aging. 2010 Mar;31(3):357-67. doi: 10.1016/j.neurobiolaging.2008.03.027. Epub 2008 May 19. Neurobiol Aging. 2010. PMID: 18486992

9

Cube copying test in combination with rCBF or CSF A beta 42 predicts development of Alzheimer's disease.

Buchhave P, Stomrud E, Warkentin S, Blennow K, Minthon L, Hansson O. Buchhave P, et al. Among authors: hansson o. Dement Geriatr Cogn Disord. 2008;25(6):544-52. doi: 10.1159/000137379. Epub 2008 Jun 6. Dement Geriatr Cogn Disord. 2008. PMID: 18535375

10

Elevated plasma levels of soluble CD40 in incipient Alzheimer's disease.

Buchhave P, Janciauskiene S, Zetterberg H, Blennow K, Minthon L, Hansson O. Buchhave P, et al. Among authors: hansson o. Neurosci Lett. 2009 Jan 23;450(1):56-9. doi: 10.1016/j.neulet.2008.10.091. Epub 2008 Nov 5. Neurosci Lett. 2009. PMID: 18996438

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

819 results

Search Page

Filters